Epidemiology, co-infections, and outcomes of viral pneumonia in adults an observational cohort study

Medicine (United States)

Volumn 94, Issue 50, 2015, Pages

  Crotty, Matthew P ^a   Meyers, Shelby ^a   Hampton, Nicholas ^b   Bledsoe, Stephanie ^a   Ritchie, David J ^a   Buller, Richard S ^c   Storch, Gregory A ^c   Micek, Scott T ^a   Kollef, Marin H ^c  

^a BARNES JEWISH HOSPITAL   (United States)

^b BJC HEALTHCARE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; OSELTAMIVIR; RIBAVIRIN; ZANAMIVIR;

ADENOVIRIDAE; ADULT; ADULT DISEASE; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BORDETELLA PERTUSSIS; CHLAMYDIA PNEUMONIAE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONAVIRIDAE; CYSTIC FIBROSIS; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; IMMUNOCOMPROMIZED PATIENT; INFLUENZA A; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; MORTALITY; MYCOPLASMA PNEUMONIAE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY VIRUS; VIRUS PNEUMONIA; AGED; COINFECTION; HOSPITAL MORTALITY; HOSPITALIZATION; INTENSIVE CARE; MICROBIOLOGY; PNEUMONIA, VIRAL; RISK FACTOR;

ADULT; AGED; COHORT STUDIES; COINFECTION; CRITICAL CARE; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, VIRAL; RISK FACTORS;

EID: 84952654880     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002332     Document Type: Article

References (32)

1. Gross AE, Van Schooneveld TC, Olsen KM, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014;58:5262-5268.
2. Andruska A, Micek ST, Shindo Y, et al. Pneumonia pathogen characterization is an independent determinant of hospital readmission. Chest. 2015;148:103-111.
3. Daubin C, Vincent S, Vabret A, et al. Nosocomial viral ventilatorassociated pneumonia in the intensive care unit: a prospective cohort study. Int Care Med. 2005;31:1116-1122.
4. Karhu J, Ala-Kokko TI, Vuorinen T, et al. Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis. 2014;59:62-70.
5. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962-970.
6. Webb SA, Pettilä V, Seppelt I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925-1934.
7. Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. CritCare Med. 2012;40:1487-1498.
8. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA. 2009;302:1896-1902.
9. Cilloniz C, Ewig S, Menendez R, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infec. 2012;65:223-230.
10. Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A (H1N1) virus. Chest. 2011;139:555-562.
11. Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics. 2011;128:e1450-e1458.
12. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis. 2003;187:1000-1009.
13. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23:S87-97.
14. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis. 2005;192:249-257.
15. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571-582.
16. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113:701-707.
17. Berkley JA, Munywoki P, Ngama M, et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA. 2010;303:2051-2057.
18. Olsen SJ, Thamthitiwat S, Chantra S, et al. Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand. Epidemiol Infect. 2010;138:1811-1822.
19. Hammitt LL, Kazungu S, Morpeth SC, et al. A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis. 2012;54:S190-199.
20. Chen CJ, Lin PY, Tsai MH, et al. Etiology of community-acquired pneumonia in hospitalized children in northern Taiwan. Pediatr Infect Dis J. 2012;31:e196-e201.
21. Techasaensiri B, Techasaensiri C, Mejías A, et al. Viral coinfections in children with invasive pneumococcal disease. Pediatr Infect Dis J. 2010;29:519-523.
22. Peltola V, Heikkinen T, Ruuskanen O, et al. Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J. 2011;30:456-461.
23. Choi SH, Hong SB, Kim T, et al. Clinical and molecular characterization of rhinoviruses A, B, and C in adult patients with pneumonia. J Clin Virol. 2015;63:70-75.
24. Kukavica-Ibrulj I, Hamelin ME, Prince GA, et al. Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J Virol. 2009;83:1341-1349.
25. Michaels RH, Myerowitz RL. Viral enhancement of nasal colonization with Haemophilus influenzae type b in the infant rat. Pediatr Res. 1983;17:472-473.
26. Oosterheert JJ, van Loon AM, Schuurman R, et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis. 2005;41:1438-1444.
27. Deng JC. Viral-bacterial interaction: therapeutic implications. Influenza Other Respir Viruses. 2013;7:24-35.
28. Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
29. Schnell D, Gits-Muselli M, Canet E, et al. Burden of respiratory viruses in patients with acute respiratory failure. J Med Virol. 2014;86:1198-1202.
30. Choi SH, Hong SB, Ko GB, et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012;186:325-332.
31. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and Creactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206-217.
32. Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis. 2011;52:S346-350.